BBNX Stock Analysis: Buy, Sell, or Hold?
BBNX - Beta Bionics, Inc. Common Stock
$12.27
-0.64 (-4.96%)
▼
5d:
+3.9%
30d:
+14.67%
90d:
-33.42%
HOLD
MODERATE Confidence
Analysis Updated: Apr 21, 2026 12:00 AM ET
Earnings: Apr 21, 2026
0d
Smart Money Accumulation
BBNX is down 4.1% this week, but smart money is accumulating calls. Top strike: $15 2026-04-17 with 13 OI. Call ratio: 100% View Scanner →
Strength: 7.0/10
Get Alerted When BBNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BBNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BBNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BBNX is currently trading at $12.27, which is considered extended relative to its 30-day fair value range of $9.74 to $11.84.
Technical Outlook: Technically, BBNX is in a strong downtrend. Immediate support is located at $8.80, while resistance sits at $13.35. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: BBNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.45 (+83.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBNX is in a strong downtrend. Immediate support is located at $8.80, while resistance sits at $13.35. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: BBNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.45 (+83.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$9.74 -
$11.84
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 83.0% below Wall St target ($22.45)
Fair Price Analysis
30-Day Fair Range
$9.74 -
$11.84
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$8.80
Resistance Level
$13.35
Current Trend
Strong Downtrend
Technical data as of
Apr 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.33
Wall Street Target
$22.45
(+83.0%)
Revenue Growth (YoY)
57.1%
Profit Margin
-73.0%
Share & Embed Analysis
Last updated: April 22, 2026 4:44 AM ET
Data refreshes hourly during market hours. Next update: 5:44 AM
Data refreshes hourly during market hours. Next update: 5:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Hopman
SELL
353 shares
2026-03-04
Mark Hopman
SELL
834 shares
2026-03-02
Mike Mensinger
SELL
1064 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$421 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$87 | 60 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$340 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
